1996
DOI: 10.1046/j.1365-2249.1996.d01-765.x
|View full text |Cite
|
Sign up to set email alerts
|

Chronic mucocutaneous candidiasis. II. Class and subclass of specific antibody responses in vivo and in vitro

Abstract: SUMMARYPatients with chronic mucocutaneous candidiasis (CMC) succumb to persistent infections with the opportunistic yeast Candida. Impaired cell-mediated responses to Candida have been repeatedly reported while antibody responses were mostly found to be normal. The underlying defect remains poorly understood. It has recently been shown that CMC patients are also susceptible to infections with encapsulated bacteria, and may have associated IgG2 and IgG4 deficiency. Our previous studies demonstrated altered cyt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
18
0

Year Published

1996
1996
2017
2017

Publication Types

Select...
4
3
2

Relationship

1
8

Authors

Journals

citations
Cited by 30 publications
(19 citation statements)
references
References 19 publications
(27 reference statements)
1
18
0
Order By: Relevance
“…The consequences of this Th2 type bias in response to CAgs would be preferential development of vigorous humoral responses, i.e. very high levels of anti-Candida antibodies (which we indeed demonstrate in the accompanying study [12]) together with low or absent cell-mediated responses (which has consistently been demonstrated both in vivo and in vitro in CMC patients [1,3,4]). As antibodies do not confer protection against fungi, the result would be an inability to clear Candida infection, as is indeed the case in CMC patients.…”
Section: Discussionsupporting
confidence: 70%
See 1 more Smart Citation
“…The consequences of this Th2 type bias in response to CAgs would be preferential development of vigorous humoral responses, i.e. very high levels of anti-Candida antibodies (which we indeed demonstrate in the accompanying study [12]) together with low or absent cell-mediated responses (which has consistently been demonstrated both in vivo and in vitro in CMC patients [1,3,4]). As antibodies do not confer protection against fungi, the result would be an inability to clear Candida infection, as is indeed the case in CMC patients.…”
Section: Discussionsupporting
confidence: 70%
“…In this and an accompanying study [12] we present results of our investigations addressing the question of cytokine production and antibody responses to antigens found on microorganisms poorly handled by CMC patients (Candida and PS antigens) and those handled well (protein antigens). We also assess various factors known to be involved in regulating levels of cytokine production: effects of in vitro addition of IFN-and IFN-on cytokine production, as both agents have been shown to exert profound effects on the types of cytokines produced, shifting the balance in favour of Th1 type cytokines [10,13]; soluble IL-6 (sIL-6R) receptors were measured, as they have been shown to upregulate IL-6 production by associating with secreted IL-6, thus promoting binding to cell membrane receptors and stimulating further IL-6 secretion [14].…”
Section: Introductionmentioning
confidence: 99%
“…20,69,70 Respiratory tract infections may be favored by low IgA, IgG2, and/or IgG4 levels as well as a poor Ab response, as documented in some patients. 71,72 The occurrence of mycobacterial and viral infections is paradoxical, as biallelic LOF STAT1 mutations underlie such infections by impairing IFN-g and IFN-a/b responses, respectively, while GOF STAT1 mono-allelic mutations enhance signaling downstream of these cytokines. 20,23,37,45,73 Viral disease might be because of exhaustion of virus-specific T cells, as described for patients with AD HIES, 74 and mycobacterial disease to refractory responses to IFN-g. 37 Patients with GOF STAT1 mutations also displayed autoimmunity, aneurysms, and malignancies.…”
Section: Discussionmentioning
confidence: 99%
“…Anti-Candida antibody levels may be normal or even elevated in chronic mucocutaneous candidiasis (28), even though recurrent mucosal infections occur in this disorder. In patients with vaginitis, serum anti-Candida antibody levels are normal or elevated (4,33).…”
mentioning
confidence: 96%